OMISIRGE for use in cord blood transplantation patients with hematologic malignancies
Tradename: OMISIRGE Proper Name: omidubicel-onlv Indication: Indicated for use in adults and pediatric patients 12 years and older with hematologic malignancies who are planned for umbilical cord blood transplantation following…